Market Overview:
The global pharmaceutical anti-counterfeiting solution market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing incidence of counterfeit drugs, rising demand for advanced authentication and track & trace technologies, and growing awareness about the benefits of using anti-counterfeiting solutions. The global pharmaceutical anti-counterfeiting solution market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into authentication technology, track & trace technology, and others. Authentication technology held a major share in 2017 owing to its ability to verify product authenticity by verifying product codes or serial numbers. Track & trace technology held a second largest share in 2017 as it enables tracking of products throughout the supply chain from manufacturer to consumer end point. Others include labeling solutions (holograms), RFID tags/labels/smart cards etc.
Product Definition:
Pharmaceutical Anti-Counterfeiting Solution is a comprehensive software application that provides manufacturers and distributors of pharmaceutical products with an effective way to protect their brands from counterfeiting. The application includes features such as product authentication, track and trace, and data security that help to ensure the authenticity of pharmaceutical products.
Authentication Technology:
The authentication technology is used to prevent the duplication of products in the supply chain. It provides a unique code or a number that can be used to determine whether an object, person or product is authentic or not. The authentication technology has gained significant traction in recent years owing to its growing adoption across various industry verticals such as BFSI, healthcare and consumer goods among others.
Track & Trace Technology:
Track and trace technology is a tool that enables pharmaceutical companies to determine the authenticity of their products. It helps them in tracing the path of every product throughout the value chain, from manufacturing to warehousing and even after sales services. This technology comprises three components such as software, devices & systems along with network connectivity which allows real-time visibility into product history.
Application Insights:
The medical and pharmaceutical application segment accounted for the largest share of the global pharmaceutical anti-counterfeiting solution market in 2017. This is due to extensive use of these solutions in this sector. For instance, Pfizer Inc., a U.S.-based multinational company, uses Anti-Counterfeiting Technology (ACT) system for original manufacturer¢â‚¬â„¢s claims as well as new drug applications (NDAs) within its supply chain operations globally.
Furthermore, other key companies operating in this industry are Sandoz AG & Co.
Regional Analysis:
Asia Pacific pharmaceutical anti-counterfeiting solution market is expected to grow at a lucrative rate over the forecast period. This growth can be attributed to increasing cases of drug counterfeiting and theft in this region. Theft of prescription drugs has grown by 43% from 2008 to 2015, with an estimated value of USD X billion stolen annually during the same period, according to a study published in The Journal Of American Medical Association (JAMA).
Theft has become more organized as criminals are increasingly targeting hospitals and pharmacies for thefts as well as bulk purchases for future distribution on the black market, researchers said. Increasing demand for generic drugs due to regulatory changes pertaining towards price control policies is also driving counterfeit drug manufacturing activities in this region which needs effective solutions against such threats.
North America pharmaceutical anti-counterfeiting solution market was valued at USD X billion in 2017 owing to high healthcare expenditure coupled with rising instances of medication counterfeiting & theft across U S.
Growth Factors:
- Increasing incidence of counterfeit drugs: The global pharmaceutical anti-counterfeiting solution market is expected to grow at a CAGR of 9.5% during the forecast period owing to the increasing incidence of counterfeit drugs. Counterfeit drugs are those that are illegally copied or produced and sold without proper authorization. They often contain incorrect ingredients, wrong dosages, or no active ingredients at all and can cause serious health risks to patients. Thus, there is a growing demand for pharmaceutical anti-counterfeiting solutions that can help identify and track fake drugs across the supply chain.
- Proliferation of online pharmacies: The growth of online pharmacies has led to an increase in the sale of counterfeit drugs as these platforms provide anonymity and easy access to illegal products. In order to combat this threat, pharmaceutical companies are increasingly adopting anti-counterfeiting solutions that can help identify fake products before they reach consumers’ hands.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Anti-Counterfeiting Solution Market Research Report
By Type
Authentication Technology, Track & Trace Technology, Others
By Application
Medical & Pharmaceutical, Package Industry, Logistics Industry, Others
By Companies
SICPA, Alpvision, 3M, Cypheme, Systech, Authentix, Avery Dennison Corporation, NanoMatriX, Covectra, DS Smith, NeuroTags, U-NICA, Constantia Flexibles, Arjo Solution, SafeTraces
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
161
Number of Tables & Figures
113
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Anti-Counterfeiting Solution Market Report Segments:
The global Pharmaceutical Anti-Counterfeiting Solution market is segmented on the basis of:
Types
Authentication Technology, Track & Trace Technology, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Medical & Pharmaceutical, Package Industry, Logistics Industry, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SICPA
- Alpvision
- 3M
- Cypheme
- Systech
- Authentix
- Avery Dennison Corporation
- NanoMatriX
- Covectra
- DS Smith
- NeuroTags
- U-NICA
- Constantia Flexibles
- Arjo Solution
- SafeTraces
Highlights of The Pharmaceutical Anti-Counterfeiting Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Authentication Technology
- Track & Trace Technology
- Others
- By Application:
- Medical & Pharmaceutical
- Package Industry
- Logistics Industry
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Anti-Counterfeiting Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A pharmaceutical anti-counterfeiting solution is a type of security measure used in the pharmaceutical industry to prevent counterfeit medications from entering the market. These solutions typically use a variety of technologies, including watermarks and holograms, to identify and track the origin of products.
Some of the key players operating in the pharmaceutical anti-counterfeiting solution market are SICPA, Alpvision, 3M, Cypheme, Systech, Authentix, Avery Dennison Corporation, NanoMatriX, Covectra, DS Smith, NeuroTags, U-NICA, Constantia Flexibles, Arjo Solution, SafeTraces.
The pharmaceutical anti-counterfeiting solution market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Anti-Counterfeiting Solution Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Anti-Counterfeiting Solution Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Anti-Counterfeiting Solution Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Anti-Counterfeiting Solution Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Anti-Counterfeiting Solution Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Anti-Counterfeiting Solution Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Anti-Counterfeiting Solution Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Anti-Counterfeiting Solution Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Type
5.2.1 Authentication Technology
5.2.2 Track & Trace Technology
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Anti-Counterfeiting Solution Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Applications
6.2.1 Medical & Pharmaceutical
6.2.2 Package Industry
6.2.3 Logistics Industry
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Anti-Counterfeiting Solution Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Anti-Counterfeiting Solution Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Type
9.6.1 Authentication Technology
9.6.2 Track & Trace Technology
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Applications
9.10.1 Medical & Pharmaceutical
9.10.2 Package Industry
9.10.3 Logistics Industry
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Anti-Counterfeiting Solution Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Type
10.6.1 Authentication Technology
10.6.2 Track & Trace Technology
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Applications
10.10.1 Medical & Pharmaceutical
10.10.2 Package Industry
10.10.3 Logistics Industry
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Anti-Counterfeiting Solution Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Type
11.6.1 Authentication Technology
11.6.2 Track & Trace Technology
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Applications
11.10.1 Medical & Pharmaceutical
11.10.2 Package Industry
11.10.3 Logistics Industry
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Anti-Counterfeiting Solution Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Type
12.6.1 Authentication Technology
12.6.2 Track & Trace Technology
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Applications
12.10.1 Medical & Pharmaceutical
12.10.2 Package Industry
12.10.3 Logistics Industry
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Anti-Counterfeiting Solution Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Type
13.6.1 Authentication Technology
13.6.2 Track & Trace Technology
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Anti-Counterfeiting Solution Market Size Forecast by Applications
13.10.1 Medical & Pharmaceutical
13.10.2 Package Industry
13.10.3 Logistics Industry
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Anti-Counterfeiting Solution Market: Competitive Dashboard
14.2 Global Pharmaceutical Anti-Counterfeiting Solution Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SICPA
14.3.2 Alpvision
14.3.3 3M
14.3.4 Cypheme
14.3.5 Systech
14.3.6 Authentix
14.3.7 Avery Dennison Corporation
14.3.8 NanoMatriX
14.3.9 Covectra
14.3.10 DS Smith
14.3.11 NeuroTags
14.3.12 U-NICA
14.3.13 Constantia Flexibles
14.3.14 Arjo Solution
14.3.15 SafeTraces
